Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
The preclinical evaluation of moxidectin as a platform for drug development for alcohol use disorder
PDF
Page 1
PDF
Role of integrin α4 in drug resistant acute lymphoblastic leukemia
PDF
The role of survivin in drug resistant pediatric acute lymphoblastic leukemia
PDF
Optimization of nanomedicine based drug delivery systems for the treatment of solid tumors
PDF
Synergism via reactive oxygen species of fenretinide combined with other anti-neoplastic agents in preclinical models of recurrent neuroblastoma
PDF
Development of ivermectin as a platform for the treatment and/or prevention of alcohol use disorders
PDF
Principles and Roadblocks in the Use of Imaging Methods in Clinical PK/PD Studies: A Perspective from the Pharmaceutical Industry, 2007
PDF
Preclinical investigation of ivermectin as a novel therapeutic agent for treatment of alcohol use disorders
PDF
Trichostatin A and dihydrotestosterone as potential multi-systemic drugs for amyotrophic lateral sclerosis
PDF
Developing recombinant single chain Fc-dimer fusion proteins for improved protein drug delivery
PDF
Computational models for drug design and delivery
PDF
Animal to human scaling and pharmacokinetic/pharmacodynamic modeling of anticancer drugs
PDF
Discovery of novel small-molecule compounds with anticancer properties
PDF
Mechanistic studies of novel small molecule anti-cancer agents using next generation sequencing
PDF
Computational methods for fluorescence molecular tomography
PDF
Computational model for predicting ionic solubility
PDF
From mesenchymal stem cell therapy to discovery of drug therapy for systemic sclerosis
PDF
An iPSC-based biomarker strategy to identify neuroregenerative responders to allopregnanolone
PDF
Engineering nanoparticles for gene therapy and cancer therapy
PDF
Pharmacokinetic and pharmacodynamic evaluations of 13-cis-retinoic acid in neuroblastoma in preclinical and clinical studies
PDF
Development of positron emission tomography (PET) labeled polypeptide nanoparticles for tumor imaging and targeting
PDF
Development of stable cell lines expressing α1β2γ2 and α5β3γ2 GABAA receptors
PDF
Development of targeted therapies for peroxisome biogenesis disorders
PDF
Therapeutic potential of rhesus theta (θ) defensin-1 in cystic fibrosis airway infection and inflammation
PDF
of 3